GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unichem Laboratories Ltd (NSE:UNICHEMLAB) » Definitions » Total Long-Term Liabilities

Unichem Laboratories (NSE:UNICHEMLAB) Total Long-Term Liabilities : ₹1,268 Mil (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Unichem Laboratories Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Unichem Laboratories's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹1,268 Mil.

Unichem Laboratories Total Long-Term Liabilities Historical Data

The historical data trend for Unichem Laboratories's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unichem Laboratories Total Long-Term Liabilities Chart

Unichem Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 631.18 1,482.36 1,181.44 990.47 1,268.40

Unichem Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 990.47 - 907.10 - 1,268.40

Unichem Laboratories Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Unichem Laboratories Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Unichem Laboratories's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Unichem Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unichem Laboratories Ltd (NSE:UNICHEMLAB) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:530239 BOM:512529 BOM:524348 BOM:524735 NSE:INNOVACAP BOM:524372 BOM:509079 BOM:532872 BOM:500288 NSE:RPGLIFE ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
506690:India
Address
Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Website
https://www.unichemlabs.com
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.

Unichem Laboratories Headlines

No Headlines